Cargando…
Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
INTRODUCTION: The emergence of multidrug-resistant Pseudomonas aeruginosa poses a global threat, but the distribution and resistance profiling are unclear, especially in young children. Infections due to P. aeruginosa are common, associated with high mortality, and increasingly β-lactam drug resista...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244630/ https://www.ncbi.nlm.nih.gov/pubmed/37293207 http://dx.doi.org/10.3389/fcimb.2023.1168096 |
_version_ | 1785054682918420480 |
---|---|
author | Patil, Sandip Chen, Xiaowen Dong, Shaowei Mai, Huirong Lopes, Bruno Silvester Liu, Sixi Wen, Feiqiu |
author_facet | Patil, Sandip Chen, Xiaowen Dong, Shaowei Mai, Huirong Lopes, Bruno Silvester Liu, Sixi Wen, Feiqiu |
author_sort | Patil, Sandip |
collection | PubMed |
description | INTRODUCTION: The emergence of multidrug-resistant Pseudomonas aeruginosa poses a global threat, but the distribution and resistance profiling are unclear, especially in young children. Infections due to P. aeruginosa are common, associated with high mortality, and increasingly β-lactam drug resistant. METHODS: We studied the molecular epidemiology and antibiotic resistance mechanisms in 294 clinicalisolates of P. aeruginosa from a pediatric hospital in China. Non-duplicate isolates were recovered from clinical cases and were identified using an API-20 kit followed by antimicrobial susceptibility testing using the VITEK®2 compact system (BioMerieux, France) and also by broth dilution method. In addition, a double-disc synergy test for the ESBL/E-test for MBL was performed. The presence of beta-lactamases, plasmid types, and sequence types was determined by PCR and sequencing. RESULTS: Fifty-six percent (n = 164) of the isolates were resistant to piperacillin–tazobactam, followed by cefepime (40%; n = 117), ceftazidime (39%; n = 115), imipenem (36%; n = 106), meropenem (33%; n = 97), and ciprofloxacin (32%; n = 94). Forty-two percent (n = 126) of the isolates were positive for ESBL according to the double-disc synergy test. The blaCTX-M-15 cephalosporinase was observed in 32% (n = 40/126), while 26% (n = 33/126) werepositive for blaNDM-1 carbapenemase. Aminoglycoside resistance gene aac(3)IIIawas observed in 16% (n = 20/126), and glycylcyclines resistance gene tet(A) was observed in 12% (n = 15/126) of the isolates. A total of 23 sequence types were detected, including ST1963 (12%; n = 16), followed by ST381 (11%; n = 14), ST234 (10%; n = 13), ST145 (58%; n = 10), ST304 (57%; n = 9), ST663 (5%; n = 7), and a novel strain. In ESBL-producing P. aeruginosa, 12 different Incompatibility groups (Inc) were observed, the most common being IncFI, IncFIS, and IncA/C. The MOBP was the most common plasmid type, followed by MOBH, MOBF, and MOBQ. DISCUSSION: Our data suggest that the spread of antibiotic resistance is likely due toclonal spread and dissemination of different clinical strains of P. aeruginosa harbouring different plasmids. This is a growing threat in hospitals particularly in young children which needs robust prevention strategies. |
format | Online Article Text |
id | pubmed-10244630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102446302023-06-08 Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children Patil, Sandip Chen, Xiaowen Dong, Shaowei Mai, Huirong Lopes, Bruno Silvester Liu, Sixi Wen, Feiqiu Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: The emergence of multidrug-resistant Pseudomonas aeruginosa poses a global threat, but the distribution and resistance profiling are unclear, especially in young children. Infections due to P. aeruginosa are common, associated with high mortality, and increasingly β-lactam drug resistant. METHODS: We studied the molecular epidemiology and antibiotic resistance mechanisms in 294 clinicalisolates of P. aeruginosa from a pediatric hospital in China. Non-duplicate isolates were recovered from clinical cases and were identified using an API-20 kit followed by antimicrobial susceptibility testing using the VITEK®2 compact system (BioMerieux, France) and also by broth dilution method. In addition, a double-disc synergy test for the ESBL/E-test for MBL was performed. The presence of beta-lactamases, plasmid types, and sequence types was determined by PCR and sequencing. RESULTS: Fifty-six percent (n = 164) of the isolates were resistant to piperacillin–tazobactam, followed by cefepime (40%; n = 117), ceftazidime (39%; n = 115), imipenem (36%; n = 106), meropenem (33%; n = 97), and ciprofloxacin (32%; n = 94). Forty-two percent (n = 126) of the isolates were positive for ESBL according to the double-disc synergy test. The blaCTX-M-15 cephalosporinase was observed in 32% (n = 40/126), while 26% (n = 33/126) werepositive for blaNDM-1 carbapenemase. Aminoglycoside resistance gene aac(3)IIIawas observed in 16% (n = 20/126), and glycylcyclines resistance gene tet(A) was observed in 12% (n = 15/126) of the isolates. A total of 23 sequence types were detected, including ST1963 (12%; n = 16), followed by ST381 (11%; n = 14), ST234 (10%; n = 13), ST145 (58%; n = 10), ST304 (57%; n = 9), ST663 (5%; n = 7), and a novel strain. In ESBL-producing P. aeruginosa, 12 different Incompatibility groups (Inc) were observed, the most common being IncFI, IncFIS, and IncA/C. The MOBP was the most common plasmid type, followed by MOBH, MOBF, and MOBQ. DISCUSSION: Our data suggest that the spread of antibiotic resistance is likely due toclonal spread and dissemination of different clinical strains of P. aeruginosa harbouring different plasmids. This is a growing threat in hospitals particularly in young children which needs robust prevention strategies. Frontiers Media S.A. 2023-05-24 /pmc/articles/PMC10244630/ /pubmed/37293207 http://dx.doi.org/10.3389/fcimb.2023.1168096 Text en Copyright © 2023 Patil, Chen, Dong, Mai, Lopes, Liu and Wen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Patil, Sandip Chen, Xiaowen Dong, Shaowei Mai, Huirong Lopes, Bruno Silvester Liu, Sixi Wen, Feiqiu Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children |
title | Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children |
title_full | Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children |
title_fullStr | Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children |
title_full_unstemmed | Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children |
title_short | Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children |
title_sort | resistance genomics and molecular epidemiology of high-risk clones of esbl-producing pseudomonas aeruginosa in young children |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244630/ https://www.ncbi.nlm.nih.gov/pubmed/37293207 http://dx.doi.org/10.3389/fcimb.2023.1168096 |
work_keys_str_mv | AT patilsandip resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren AT chenxiaowen resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren AT dongshaowei resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren AT maihuirong resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren AT lopesbrunosilvester resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren AT liusixi resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren AT wenfeiqiu resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren |